Converting tumor-specific markers into reporters of oncolytic virus infection

Molecular Therapy

Volumn 17, Issue 8, 2009, Pages 1395-1403

  Iankov, Ianko D ^a   Hillestad, Matthew L ^a   Dietz, Allan B ^a   Russell, Stephen J ^a   Galanis, Evanthia ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; ONCOLYTIC VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCING CELL; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL SECRETION; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MEASLES VIRUS; MOUSE; MULTIPLE MYELOMA; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROTEIN EXPRESSION; REPORTER GENE; TREATMENT RESPONSE; VIRAL GENE THERAPY;

ANIMALIA; MEASLES VIRUS;

EID: 68249120554     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.92     Document Type: Article

References (47)

1. Russell, SJ and Peng, KW (2007). Viruses as anticancer drugs. Trends Pharmacol Sci 28: 326-333.
2. Ungerechts, G, Springfeld, C, Frenzke, ME, Lampe, J, Johnston, PB, Parker, WB et al. (2007). Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. Cancer Res 67: 10939-10947.
3. Carlson, SK, Classic, KL, Hadac, EM, Bender, CE, Kemp, BJ, Lowe, VJ et al. (2006). In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography. Mol Imaging Biol 8: 324-332.
4. Dingli, D, Peng, KW, Harvey, ME, Greipp, PR, O'Connor, MK, Cattaneo, R et al. (2004). Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 103: 1641-1646.
5. Dwyer, RM, Schatz, SM, Bergert, ER, Myers, RM, Harvey, ME, Classic, KL et al. (2005). A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther 12: 835-841.
6. Dwyer, RM, Bergert, ER, O'Connor, MK, Gendler, SJ and Morris, JC (2006). Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther 13: 60-66.
7. Spitzweg, C, Baker, CH, Bergert, ER, O'Connor, MK and Morris, JC (2007). Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum Gene Ther 18: 916-924.
8. Bennett, JJ, Tjuvajev, J, Johnson, P, Doubrovin, M, Akhurst, T, Malholtra, S et al. (2001). Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med 7: 859-863.
9. Green, LA, Yap, CS, Nguyen, K, Barrio, JR, Namavari, M, Satyamurthy, N et al. (2002). Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. Mol Imaging Biol 4: 71-81.
10. Gross, S and Piwnica-Worms, D (2005). Spying on cancer: Molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7: 5-15.
11. Kuruppu, D, Dorfman, JD and Tanabe, KK (2007). HSV-1 viral oncolysis and molecular imaging with PET. Curr Cancer Drug Targets 7: 175-180.
12. Peng, KW, Facteau, S, Wegman, T, O'Kane, D and Russell, SJ (2002). Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nat Med 8: 527-531.
13. Rajkumar, SV and Kyle, RA (2005). Multiple myeloma: Diagnosis and treatment. Mayo Clin Proc 80: 1371-1382.
14. Kumar, SK, Rajkumar, SV, Dispenzieri, A, Lacy, HQ, Hayman, SR, Bauadi, FK et al. (2008). Improved survival in multiple myeloma and the impact of novel therapies. Blood 111: 2516-2520.
15. Murphy, K, Travers, P and Walport, M (eds) (2008). Antigen recognition by B-cell and T-cell receptor. In: Janeway's Immunobiology. Garland Science, Taylor & Francis Group: New York and London, pp. 111-142.
16. Murphy, K, Travers, P and Walport, M (eds) (2008). The generation of lymphocyte antigen receptors. In: Janeway's Immunobiology, Garland Science, Taylor & Francis Group: New York and London, pp. 143-179.
17. Solomon, A (1986). Light chains of immunoglobulins: Structural-genetic correlates. Blood 68: 603-610.
18. Griffin, D (2001). Measles virus. In: Knipe, DM and Howley, PM, (eds). Fields Virology. Lippincott Williams & Wilkins: Philadelphia, pp 1401-1441.
19. Iankov, ID, Blechacz, B, Liu, C, Schmeckpeper, JD, Tarara, JE, Federspiel, MJ et al. (2007). Infected cell carriers: A new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy. Mol Ther 15: 114-122.
20. Mrkic, B, Pavlovic, J, Rülicke, T, Volpe, P, Buchholz, CJ, Hourcade, D et al. (1998). Measles virus spread and pathogenesis in genetically modified mice. J Virol 72: 7420-7427.
21. Saitta, M, Iavarone, A, Cappello, N, Bergami, MR, Fiorucci, GC and Aguzzi, F (1992). Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum. Clin Chem 38: 2454-2457.
22. Hamrock, DJ (2006). Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol 6: 535-542.
23. Pratt, G (2008). The evolving use of serum free light chain assays in haematology. Br J Haematol 141: 413-422.
24. Iankov, ID, Pandey, M, Harvey, M, Griesmann, GE, Federspiel, MJ and Russell, SJ (2006). Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol 80: 8530-8540.
25. Allen, C, Vongpunsawad, S, Nakamura, T, James, CD, Schroeder, M, Cattaneo, R et al. (2006). Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Res 66: 11840-11850.
26. Grote, D, Russell, SJ, Cornu, TI, Cattaneo, R, Vile, R, Poland, GA et al. (2001). Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood 97: 3746-3754.
27. McDonald, CJ, Erlichman, C, Ingle, JN, Rosales, GA, Allen, C, Greiner, SM et al. (2006). A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer. Breast Cancer Res Treat 99: 177-184.
28. Peng, KW, TenEyck, CJ, Galanis, E, Kalli, KR, Hartmann, LC and Russell, SJ (2002). Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 62: 4656-4662.
29. Peng, KW, Ahmann, GJ, Pham, L, Greipp, PR, Cattaneo, R and Russell, SJ (2001). Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood 98: 2002-2007.
30. Phuong, LK, Allen, C, Peng, KW, Giannini, C, Greiner, S, TenEyck, CJ et al. (2003). Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 63: 2462-2469.
31. Yanagi, Y, Takeda, M and Ohno, S (2006). Measles virus: Cellular receptors, tropism and pathogenesis. J Gen Virol 87(Pt 10): 2767-2779.
32. Kyle, RA, Gertz, MA, Witzig, TE, Lust, JA, Lacy, MQ, Dispenzieri, A et al. (2003). Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78: 21-33.
33. Borgoño, CA, Michael, IP and Diamandis, EP (2004). Human tissue kallikreins: Physiologic roles and applications in cancer. Mol Cancer Res 2: 257-280.
34. Munguia, A, Ota, T, Miest, T and Russell, SJ (2008). Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth. Gene Ther 15: 797-806.
35. Esolen, LM, Ward, BJ, Moench, TR and Griffin, DE (1993). Infection of monocytes during measles. J Infect Dis 168: 47-52.
36. Forthal, DN, Landucci, G, Habis, A, Zartarian, M, Katz, J and Tilles, JG (1994). Measles virus-specific functional antibody responses and viremia during acute measles. J Infect Dis 169: 1377-1380.
37. Barrios, Y, Plaza, A, Cabrera, R, Yáñez, R, Suárez, E, Fernández, MN et al. (2001). Active idiotypic vaccination in a patient with biclonal follicular lymphoma. Cancer Immunol Immunother 50: 87-92.
38. Barrios, Y, Cabrera, R, Yáñez, R, Briz, M, Plaza, A, Forés, R et al. (2002). Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma. Haematologica 87: 400-407.
39. Timmerman, JM, Czerwinski, DK, Davis, TA, Hsu, FJ, Benike, C, Hao, ZM et al. (2002). Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: Clinical and immune responses in 35 patients. Blood 99: 1517-1526.
40. Duprex, WP, McQuaid, S, Roscic-Mrkic, B, Cattaneo, R, McCallister, C and Rima, BK (2000). In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Virol 74: 7972-7979.
41. Radecke, F, Spielhofer, P, Schneider, H, Kaelin, K, Huber, M, Dötsch, C et al. (1995). Rescue of measles viruses from cloned DNA. EMBO J 14: 5773-5784.
42. Dietz, AB, Bulur, PA, Knutson, GJ, Matasic, R and Vuk-Pavlovic, S (2000). Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem Biophys Res Commun 275: 731-738.
43. Dietz, AB, Bulur, PA, Emery, RL, Winters, JL, Epps, DE, Zubair, AC et al. (2006). A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 46: 2083-2089.
44. Duprex, WP, McQuaid, S, Hangartner, L, Billeter, MA and Rima, BK (1999). Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J Virol 73: 9568-9575.
45. Myers, R, Greiner, S, Harvey, M, Soeffker, D, Frenzke, M, Abraham, K et al. (2005). Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer. Cancer Gene Ther 12: 593-599.
46. Mrkic, B, Odermatt, B, Klein, MA, Billeter, MA, Pavlovic, J and Cattaneo, R (2000). Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol 74: 1364-1372.
47. Roscic-Mrkic, B, Schwendener, RA, Odermatt, B, Zuniga, A, Pavlovic, J, Billeter, MA et al. (2001). Roles of macrophages in measles virus infection of genetically modified mice. J Virol 75: 3343-3351.